AAAAAA

   
Results: 1-16 |
Results: 16
RADIOTHERAPY WITH HIGH-DOSE-RATE BRACHYTHERAPY BOOST AND CONCOMITANT CHEMOTHERAPY FOR STAGE-IIB AND STAGE-III ESOPHAGEAL-CARCINOMA - RESULTS OF A PILOT-STUDY
Authors: CALAIS G DORVAL E LOUISOT P BOURLIER P KLEIN V CHAPET S REYNAUDBOUGNOUX A HUTEN N DECALAN L AGET H LEFLOCH O
Citation: G. Calais et al., RADIOTHERAPY WITH HIGH-DOSE-RATE BRACHYTHERAPY BOOST AND CONCOMITANT CHEMOTHERAPY FOR STAGE-IIB AND STAGE-III ESOPHAGEAL-CARCINOMA - RESULTS OF A PILOT-STUDY, International journal of radiation oncology, biology, physics, 38(4), 1997, pp. 769-775
PREOPERATIVE RADIOTHERAPY (RT) FOR RECTAL-CANCER - PREDICTIVE FACTORSOF TUMOR DOWNSTAGING AND RESIDUAL TUMOR-CELL DENSITY (RTCD) - PROGNOSTIC IMPLICATIONS
Authors: BERGER C DEMURET A GARAUD P CHAPET S BOURLIER P REYNAUDBOUGNOUX A DORVAL E DECALAN L HUTEN N LEFLOCH O CALAIS G
Citation: C. Berger et al., PREOPERATIVE RADIOTHERAPY (RT) FOR RECTAL-CANCER - PREDICTIVE FACTORSOF TUMOR DOWNSTAGING AND RESIDUAL TUMOR-CELL DENSITY (RTCD) - PROGNOSTIC IMPLICATIONS, International journal of radiation oncology, biology, physics, 37(3), 1997, pp. 619-627
PREDICTORS OF DISTANT RECURRENCE IN CLINICAL STAGE-I OR STAGE-II ENDOMETRIAL CARCINOMA TREATED BY COMBINATION SURGICAL AND RADIATION-THERAPY
Authors: DESCAMPS P CALAIS G MOIRE C BERTRAND P CASTIEL M LEFLOCH O LANSAC J BODY G
Citation: P. Descamps et al., PREDICTORS OF DISTANT RECURRENCE IN CLINICAL STAGE-I OR STAGE-II ENDOMETRIAL CARCINOMA TREATED BY COMBINATION SURGICAL AND RADIATION-THERAPY, Gynecologic oncology, 64(1), 1997, pp. 54-58
RETROPERITONEAL MALIGNANT FIBROUS HISTIOC YTOMA
Authors: FIGNON A MARRET H BODY G SAILE N LANSON Y LEFLOCH O FETISSOF F
Citation: A. Fignon et al., RETROPERITONEAL MALIGNANT FIBROUS HISTIOC YTOMA, Annales de chirurgie, 51(9), 1997, pp. 1023-1027
ENHANCED ACUTE TOXICITY IN OROPHARYNX CARCINOMA TREATED WITH RADIOTHERAPY AND CONCOMITANT CISPLATIN, 5-FLUOROURACIL AND MITOMYCIN-C
Authors: BERGER C CHAPET S REYNAUDBOUGNOUX A GARAND G LEFLOCH O CALAIS G
Citation: C. Berger et al., ENHANCED ACUTE TOXICITY IN OROPHARYNX CARCINOMA TREATED WITH RADIOTHERAPY AND CONCOMITANT CISPLATIN, 5-FLUOROURACIL AND MITOMYCIN-C, European journal of cancer, 32A(10), 1996, pp. 1707-1711
A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF IV DOLASETRON MESILATE INTHE PREVENTION OF RADIOTHERAPY-INDUCED NAUSEA AND VOMITING IN CANCER-PATIENTS
Authors: BEY P WILKINSON PM RESBEUT M BOURDIN S LEFLOCH O HAHNE W CLAVERIE N
Citation: P. Bey et al., A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF IV DOLASETRON MESILATE INTHE PREVENTION OF RADIOTHERAPY-INDUCED NAUSEA AND VOMITING IN CANCER-PATIENTS, Supportive care in cancer, 4(5), 1996, pp. 378-383
PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL COMPARING NEOADJUVANT CHEMOTHERAPY (CISPLATIN, EPIRUBICIN, BLEOMYCIN) PLUS RADIOTHERAPY VS RADIOTHERAPY ALONE IN STAGE-IV (GREATER-THAN-OR-EQUAL-TO-N2, M0) UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA - A POSITIVE EFFECT ON PROGRESSION-FREESURVIVAL
Authors: CVITKOVIC E ESCHWEGE F RAHAL M",DOSEN,"MERSIC Z KRAJINA Z ARMAND JP BOUHRIS J TUBIANAMATHIEU M FOUNTZILAS G KOSMIDIS PA PRASAD U GANESAN S ELGUEDDARI B BACHOUCHI M MANSOURI A OLIVEIRA J RAPOSO J WIERZBICKI R LIANES P PENA C ONAT H ALTUN M BENHAMOU E DUCOURTIEUX M AZLI N FANDI A TAAMMA A BOSQ J KLIJANIENKO J SIGAL R HONG WK VOKES EE CLARK JR LEFLOCH O BERNIER J
Citation: E. Cvitkovic et al., PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL COMPARING NEOADJUVANT CHEMOTHERAPY (CISPLATIN, EPIRUBICIN, BLEOMYCIN) PLUS RADIOTHERAPY VS RADIOTHERAPY ALONE IN STAGE-IV (GREATER-THAN-OR-EQUAL-TO-N2, M0) UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA - A POSITIVE EFFECT ON PROGRESSION-FREESURVIVAL, International journal of radiation oncology, biology, physics, 35(3), 1996, pp. 463-469
POSTOPERATIVE RADIOTHERAPY AND CONCOMITANT ADJUVANT CHEMOTHERAPY FOR BREAST-CARCINOMA
Authors: REYNAUDBOUGNOUX A MERCIER P DESCAMPS P CALAIS G CHAPET S BERGER C LEFLOCH O BODY G
Citation: A. Reynaudbougnoux et al., POSTOPERATIVE RADIOTHERAPY AND CONCOMITANT ADJUVANT CHEMOTHERAPY FOR BREAST-CARCINOMA, European journal of cancer, 31A, 1995, pp. 73-73
RADIATION NECROSIS OF THE MANDIBLE AFTER RADIOTHERAPY OF 921 OROPHARYNX AND ORAL CAVITY CARCINOMAS
Authors: CALAIS G CHAPET S BERGER C REYNAUDBOUGNOUX A LEFLOCH O
Citation: G. Calais et al., RADIATION NECROSIS OF THE MANDIBLE AFTER RADIOTHERAPY OF 921 OROPHARYNX AND ORAL CAVITY CARCINOMAS, European journal of cancer, 31A, 1995, pp. 388-388
HIGH-DOSE RADIOTHERAPY (RT), CONCOMITANT CHEMOTHERAPY (CT) AND HIGH-DOSE-RATE BRACHYTHERAPY FOR NON RESECTABLE ESOPHAGEAL CANCER
Authors: CALAIS G DORVAL E CHAPET S BERGER C REYNAUDBOUGNOUX A HUTEN N DECALAN L LEFLOCH O
Citation: G. Calais et al., HIGH-DOSE RADIOTHERAPY (RT), CONCOMITANT CHEMOTHERAPY (CT) AND HIGH-DOSE-RATE BRACHYTHERAPY FOR NON RESECTABLE ESOPHAGEAL CANCER, European journal of cancer, 31A, 1995, pp. 551-551
PROGNOSTIC VALUE AND PREDICTIVE FACTORS OF TUMOR STERILIZATION AFTER PREOPERATIVE RADIOTHERAPY FOR RECTAL-CANCER
Authors: BERGER C DEMURET A CHAPET S CALAIS G REYNAUDBOUGNOUX A DORVAL E DECALAN L HUTEN N LEFLOCH O
Citation: C. Berger et al., PROGNOSTIC VALUE AND PREDICTIVE FACTORS OF TUMOR STERILIZATION AFTER PREOPERATIVE RADIOTHERAPY FOR RECTAL-CANCER, European journal of cancer, 31A, 1995, pp. 707-707
PROGNOSTIC VALUE OF HISTOLOGICAL TUMOR-REGRESSION AFTER IRRADIATION FOR UTERINE CERVIX CARCINOMA
Authors: CHAPET S BERGER C CALAIS G REYNAUDBOUGNOUX A DESCAMPS P BODY G LEFLOCH O
Citation: S. Chapet et al., PROGNOSTIC VALUE OF HISTOLOGICAL TUMOR-REGRESSION AFTER IRRADIATION FOR UTERINE CERVIX CARCINOMA, European journal of cancer, 31A, 1995, pp. 1177-1177
ABDOMINO PELVIC IRRADIATION AFTER 2ND-LOOK LAPAROTOMY FOR STAGE-III OVARIAN-CARCINOMA
Authors: CHAPET S BERGER C FIGNON A CALAIS G FETISSOF F REYNAUDBOUGNOUX A DESCAMPS P BODY G LANSAC J LEFLOCH O
Citation: S. Chapet et al., ABDOMINO PELVIC IRRADIATION AFTER 2ND-LOOK LAPAROTOMY FOR STAGE-III OVARIAN-CARCINOMA, European journal of obstetrics, gynecology, and reproductive biology, 62(1), 1995, pp. 43-48
CONCOMITANT RADIOCHEMOTHERAPY WITH CISPLA TIN (CDDP), 5-FLUOROURACIL (5-FU) AND MITOMYCIN-C (MMC) IN LOCALLY ADVANCED OROPHARYNGEAL CARCINOMA - RESULTS OF A PHASE-II TRIAL
Authors: BERGER C CHAPET S CALAIS G REYNAUDBOUGNOUX A GARAND G LEFLOCH O
Citation: C. Berger et al., CONCOMITANT RADIOCHEMOTHERAPY WITH CISPLA TIN (CDDP), 5-FLUOROURACIL (5-FU) AND MITOMYCIN-C (MMC) IN LOCALLY ADVANCED OROPHARYNGEAL CARCINOMA - RESULTS OF A PHASE-II TRIAL, Bulletin du cancer, 82(12), 1995, pp. 1044-1051
CONSERVATIVE TREATMENT FEASIBILITY WITH INDUCTION CHEMOTHERAPY, SURGERY, AND RADIOTHERAPY FOR PATIENTS WITH BREAST-CARCINOMA LARGER THAN 3 CM
Authors: CALAIS G BERGER C DESCAMPS P CHAPET S REYNAUDBOUGNOUX A BODY G BOUGNOUX P LANSAC J LEFLOCH O
Citation: G. Calais et al., CONSERVATIVE TREATMENT FEASIBILITY WITH INDUCTION CHEMOTHERAPY, SURGERY, AND RADIOTHERAPY FOR PATIENTS WITH BREAST-CARCINOMA LARGER THAN 3 CM, Cancer, 74(4), 1994, pp. 1283-1288
PRIMARY CHEMOTHERAPY AND RADIOSURGICAL BREAST-CONSERVING TREATMENT FOR PATIENTS WITH LOCALLY ADVANCED OPERABLE BREAST CANCERS
Authors: CALAIS G DESCAMPS P CHAPET S TURGEON V REYNAUDBOUGNOUX A LEMARIE E FIGNON A BODY G BOUGNOUX P LANSAC J LEFLOCH O
Citation: G. Calais et al., PRIMARY CHEMOTHERAPY AND RADIOSURGICAL BREAST-CONSERVING TREATMENT FOR PATIENTS WITH LOCALLY ADVANCED OPERABLE BREAST CANCERS, International journal of radiation oncology, biology, physics, 26(1), 1993, pp. 37-42
Risultati: 1-16 |